Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Neurology|July 23, 2026
Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025: A Systematic ReviewCan Li, Mengyuan Fu, Karina Berg, et al.
JAMA Network Open|August 10, 2022
Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020Yichen Zhang, Huseyin Naci, Anita K Wagner, et al.
Research in Social & Administrative Pharmacy : RSAP|August 27, 2025
Association of longer-term versus shorter-term antihypertensives prescriptions and clinical outcomes in patients with hypertension: A population-based propensity score matching studyTao Huang, Lin Bai, Huangqianyu Li, et al.
The Lancet Regional Health. Western Pacific|July 26, 2024
Evaluation of appropriateness of antibiotic prescribing in primary healthcare institutions in China using proxy indicatorHaishaerjiang Wushouer, Junxuan Yu, Kexin Du, et al.
International Journal of Antimicrobial Agents|December 23, 2023
The changes of different restriction level adjustments on antibiotic use in ChinaKexin Du, Haishaerjiang Wushouer, Tao Huang, et al.
BMC Health Services Research|August 18, 2021
Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015-2018Yumiti Taxifulati, Haishaerjiang Wushouer, Mengyuan Fu, et al.
Eclinicalmedicine|March 29, 2024
Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysisZhuo Ma, Huangqianyu Li, Yi Zhang, et al.
Diabetes Technology & Therapeutics|November 7, 2014
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysisFeng Sun, Sanbao Chai, Kai Yu, et al.
Bjpsych Open|February 5, 2026
Psychotropic medication prescribing for patients with insomnia comorbid with depressive or anxiety disorders in primary healthcare facilities in BeijingMengyuan Fu, Can Li, Xinyi Zhou, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2024
The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation AnalysisTiansheng Wang, Dongze Ji, Til Stürmer, et al.
Pageof 14